[Clinical experiences with pyrazinobutazonean equimoleculer combination of phenylbutazone and piperazine].
D000328:Adult; D000368:Aged; D002214:Capsules; D004338:Drug Combinations; D004357:Drug Synergism; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010653:Phenylbutazone / Q000008:administration & dosage*; D010879:Piperazines / Q000008:administration & dosage*; D012216:Rheumatic Diseases / Q000188:drug therapy*; D013488:Suppositories
D002214:Capsules; D004338:Drug Combinations; D010879:Piperazines; D013488:Suppositories; D010653:Phenylbutazone
Uber klinische Erfahrungen mit Pyrazinobutazon, einer äquimolekularen Verbindung von Phenylbutazon und Piperazin.